A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis ; day:14 ; month:07 ; year:2022 ; extent:23
EMBO molecular medicine / European Molecular Biology Organization ; (14.07.2022) (gesamt 23)
- Creator
-
Booijink, Richell
Salgado‐Polo, Fernando
Jamieson, Craig
Perrakis, Anastassis
Bansal, Ruchi
- DOI
-
10.15252/emmm.202216333
- URN
-
urn:nbn:de:101:1-2022071415313839684495
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Booijink, Richell
- Salgado‐Polo, Fernando
- Jamieson, Craig
- Perrakis, Anastassis
- Bansal, Ruchi
Other Objects (12)
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism